Day: November 13, 2023

Eloxx Pharmaceuticals Reports Third Quarter 2023 Financial and Operating Results and Provides Business Update

Kidney morphology improved in all three patients with protein re-expression consistent with disease regression in its Phase 2 open-label clinical trial of ELX-02 for the treatment of Alport Syndrome ELX-02 improved podocyte foot process effacement in all three treated patients by an average of 60% based on blinded biopsy analysis by NIPOKA GmbH Clinical data from Phase 2 study of ELX-02 for Alport Syndrome included in presentations at the American Society of Nephrology (ASN) Kidney Week 2023 Significant progress toward completion of a strategic partnership for ZKN-013 WATERTOWN, Mass., Nov. 13, 2023 (GLOBE NEWSWIRE) — Eloxx Pharmaceuticals, Inc. (OTC: ELOX), a leader in ribosomal RNA-targeted genetic therapies for rare diseases, today reported its financial results for the three months ended September 30, 2023, and provided a business...

Continue reading

Senti Bio Announces Third Quarter 2023 Results and Pipeline Updates

– IND for SENTI-202, a potential first-in-class logic-gated treatment for cancer, on track for clearance in Q4 2023 – – Established new strategic collaboration with Celest Therapeutics for clinical development of SENTI-301A to treat liver cancer in China – – Cash and receivables from GeneFab transaction expected to fund operations into Q4 2024 – SOUTH SAN FRANCISCO, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) — Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today reported financial results for the third quarter of 2023. “The third quarter was highly productive for Senti as we continued advancing SENTI-202 towards IND clearance and further developed our platform technology,” said Timothy Lu, MD, PhD, Chief Executive...

Continue reading

eFFECTOR Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Management intends to provide an update on its zotatifin clinical development program in estrogen receptor-positive (ER+) metastatic breast cancer (mBC) at the 2023 San Antonio Breast Cancer Symposium (SABCS) Topline results from Phase 2b KICKSTART trial in non-small cell lung cancer (NSCLC) now anticipated in first quarter of 2024 Collaboration initiated with Northwestern University on investigator-initiated Phase 1 dose escalation trial with tomivosertib in patients with Acute Myeloid Leukemia (AML) SOLANA BEACH, Calif. and REDWOOD CITY, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) — eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer, today reported financial results for the third quarter ended September 30, 2023 and provided a corporate...

Continue reading

Core Molding Technologies Presenting at the 15th Annual Southwest IDEAS Investor Conference on November 16th in Dallas, TX

COLUMBUS, Ohio, Nov. 13, 2023 (GLOBE NEWSWIRE) — Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding”, “Core” or the “Company”), a leading engineered materials company specializing in molded structural products, principally in building products, industrial and utilities, medium and heavy-duty truck and powersports industries across the United States, Canada and Mexico today announced that the Company will present at the Southwest IDEAS Investor Conference at 10:05 am CT on November 16, 2023, at The Statler Dallas, and management will also be available for 1×1 meetings that day. The presentation will be webcast and may be accessed through the conference host’s main website: https://www.threepartadvisors.com/southwest and in the investor relations section of the company’s website: https://coremt.com/investor-relations/events-presentations/. About...

Continue reading

MDxHealth Announces Completion of Share Consolidation, and Update of Outstanding Shares and Voting Rights

           NEWS RELEASE – REGULATED INFORMATIONINSIDE INFORMATIONNOVEMBER 13, 2023, 4:00 PM ET / 22:00 CET MDxHealth Announces Completion of Share Consolidation, and Update of Outstanding Shares and Voting Rights IRVINE, CA, and HERSTAL, BELGIUM – November 13, 2023 – MDxHealth SA (NASDAQ/Euronext: MDXH) (“mdxhealth” or the “Company”), a commercial-stage precision diagnostics company, today announces that it completed the share consolidation with respect to all its outstanding shares by means of a 1-for-10 reverse stock split (the “Share Consolidation”), the details of which were announced by press release on November 6, 2023. After close of trading on the regulated market Euronext Brussels, all 272,880,936 Company’s shares (ISIN BE0003844611) were consolidated into a new and reduced number...

Continue reading

HII Celebrates National Apprenticeship Week

National Apprenticeship Week 2023 HII is celebrating National Apprenticeship Week. Apprenticeships are offered at each of HII’s three business divisions, including Newport News Shipbuilding. NEWPORT NEWS, Va., Nov. 13, 2023 (GLOBE NEWSWIRE) — HII (NYSE: HII), America’s largest military shipbuilder and provider of all-domain defense solutions, is celebrating National Apprenticeship Week. Recognized by the U.S. Department of Labor, National Apprenticeship Week this year runs Nov. 13-19. It is an opportunity to highlight the success and value of apprenticeships in supporting economic growth and access to high-quality jobs. Apprenticeships are offered at each of HII’s three business divisions: Ingalls Shipbuilding, Mission Technologies and Newport News Shipbuilding. “Apprenticeship programs are the foundation in our workforce...

Continue reading

Watsco to Present at the Stephens Annual Investment Conference on November 14, 2023

MIAMI, Nov. 13, 2023 (GLOBE NEWSWIRE) — Watsco, Inc. (NYSE: WSO) announced today that Enrique (Rick) Gomez, Vice President, is scheduled to speak at the Stephens Annual Investment Conference being held at the Grand Hyatt in Nashville, Tennessee on Tuesday, November 14, 2023 at 3:00 p.m. (ET). Internet users can listen to a live webcast of the presentation at the Investor Relations section of Watsco’s website at www.watsco.com. About Watsco Watsco operates the largest distribution network for heating, air conditioning and refrigeration (HVAC/R) products with locations in the United States, Canada, Mexico and Puerto Rico, and on an export basis to Latin America and the Caribbean. Watsco estimates that over 350,000 contractors and technicians visit or call one of its 691 locations each year to get information, obtain technical support...

Continue reading

Carlyle Secured Lending, Inc. Prices Public Offering of 8.20% Notes Due 2028

NEW YORK, Nov. 13, 2023 (GLOBE NEWSWIRE) — Carlyle Secured Lending, Inc. (Nasdaq: CGBD) (the “Company”) today announced that it has priced an underwritten public offering of $75.0 million aggregate principal amount of 8.20% unsecured notes due 2028 (the “Notes”). The Notes will mature on December 1, 2028 and may be redeemed in whole or in part at any time or from time to time at the Company’s option on or after December 1, 2025. The Notes will bear interest at a rate of 8.20% per year payable quarterly on March 1, June 1, September 1, and December 1 of each year, beginning March 1, 2024. The Company also granted the underwriters a 30-day option to purchase up to an additional $10.0 million aggregate principal amount of the Notes, solely to cover overallotments, if any. The offering is expected to close on...

Continue reading

Grieg Seafood ASA: Extending post-smolt in Finnmark and assessing partners to expedite growth prospects in Canada

Grieg Seafood has decided to invest NOK 1.1 billion in a new post-smolt unit at its smolt facility in Finnmark. It thereby moves forward with the investment as originally planned and increases annual production of post-smolt from 1,800 to 4,800 tonnes in the region. Following the announcement of a resource tax on the salmon industry in Norway in 2022, Grieg Seafood has until recently put all investments on hold. While many technical details of the tax are still unclear, the final tax was improved from the original version. Grieg Seafood has now chosen to prioritize the post-smolt expansion in Finnmark as the first investment as it is expected to drive biological control, earnings and sustainability. Commenting on the decision, Andreas Kvame, CEO of Grieg Seafood ASA (“the Company”), says: “The 25 percent resource tax has reduced...

Continue reading

Sypris Solutions, Inc. to Announce Third Quarter Financial Results, Host Conference Call and Webcast November 15

LOUISVILLE, Ky., Nov. 13, 2023 (GLOBE NEWSWIRE) — Sypris Solutions, Inc. (NASDAQ/GM: SYPR) (“Sypris” or the “Company”) today announced that it will host a conference call on Wednesday, November 15, 2023, at 9:00 a.m. ET to discuss financial results and operations. To listen to the call live via telephone, participants should dial (833) 316-0560 approximately 10 minutes prior to the start of the call (ask to be joined into the Sypris Solutions, Inc. call). The live broadcast of Sypris’ quarterly conference call will also be available online at www.sypris.com on November 15, 2023, beginning at 9:00 a.m. (Eastern Time). The online replay will be available at approximately 11:00 a.m. (Eastern Time) and continue for 30 days. Related presentation materials will be posted to the “Investor Information” section of the Company’s website...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.